Back to search results

Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Castration-resistant Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope, Duarte, California, United States

    Contact: Study coordinator (Tanya Dorff, MD) · tdorff@coh.org · 626-256-4673

  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Clinical Trial Recruitment Navigator) · cancer.trial.info@cshs.org · 310-423-2133
    Robert Figlin, MD FACP (Sub-investigator)
    Jun Gong, MD (Sub-investigator)
    Kevin Scher, MD MBA (Sub-investigator)
    David Hoffman, MD (Sub-investigator)
    Leland Green, MD (Sub-investigator)
    Kristopher Wentzel, MD (Sub-investigator)

  • Huntsman Cancer Institute and Hospital, Salt Lake City, Utah, United States

    Contact: Study coordinator (Umang Swami, MD) · Umang.Swami@hci.utah.edu · 801-587-4381
Study leads

  • Edwin Posadas, MD FACP

    Principal Investigator

    Cedars-Sinai Medical Center

View source on ClinicalTrials.gov(opens in a new tab)